Article
Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes
31 Aug 2021
Abstract excerpt
p53 is mutated in over half of human cancers. In addition to losing wild-type (WT) tumor-suppressive function, mutant p53 proteins are proposed to acquire gain-of-function (GOF) activity, leading to novel oncogenic phenotypes. To study mutant p53 GOF mechanisms and phenotypes, we genetically engineered non-transformed and tumor-derived WT p53 cell line models to express endogenous missense mutant p53 (R175H and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
